BRITTANY SHENK: Open Payments
NPI 1619523222 · STAFFORD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$625 in 27 payments from 14 companies in 2025. Trend: 2023 $184 · 2024 $197 · 2025 $625
Food & beverage: $625
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $157 |
| ABBVIE INC. | 3 | $68 |
| Abbott Laboratories | 3 | $59 |
| Biogen, Inc. | 3 | $58 |
| Sumitomo Pharma America, Inc. | 2 | $54 |
| Organon LLC | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Astellas Pharma US Inc | 1 | $33 |
| Smith+Nephew, Inc. | 1 | $24 |
| Amgen Inc. | 1 | $21 |
Products named: Ozempic, FREESTYLE LIBRE 3, ZURZUVAE, NEXPLANON, QULIPTA, Mirena, Rybelsus, Veozah.
Industry payments across VA — which companies pay providers there.
